Nuvectis intends to use the net proceeds from the offering to continue to advance the development programs of NXP800 and NXP900 or any future product candidate, hiring of additional personnel, capital ...

Northpointe Bancshares is targeting a valuation of up to $595 million in its initial public offering in the United States, ...

IPO-bound Droom's financial health has declined, with its revenue from operations nosediving by two-thirds during the last ...

RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a life sciences company developing novel targeted oncology therapies and commercializing ...

Some Iowans have raised concerns following allegations that Lutheran churches and organizations are using federal grants as a ...

Titan America SA and its owner Titan Cement International SA raised $384 million in an initial public offering, pricing its ...

Titan America has raised $384 million after pricing its U.S. initial public offering at $16 per share, within its targeted range, the cement producer said on Thursday.

Gemini’s reported fresh IPO plans come as crypto asset manager Bitwise predicted that at least five “crypto unicorns” would ...

MALVERN, Pa. - Neuronetics , Inc. (NASDAQ: NASDAQ:STIM), a global leader in neuroscience with a market capitalization of $197 million, has launched an underwritten public offering of its common stock, ...

MOUNTAIN VIEW, Calif. - RenovoRx , Inc. (NASDAQ:RNXT), a $35.7 million market cap developer of targeted oncology therapies, has initiated an underwritten public offering of its common stock and ...

Insights on recent performance, challenges, and potential opportunities for investors. Click for more on PGNY stock prospects ...

(NASDAQ: STIM) (the “Company”) today announced that it has commenced an underwritten public offering of its common stock. In connection with the offering, the Company expects to grant the underwriter ...